Search

Your search keyword '"Marcin, Lawrence"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Marcin, Lawrence" Remove constraint Author: "Marcin, Lawrence"
44 results on '"Marcin, Lawrence"'

Search Results

2. Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia

4. Asymmetric construction of a quaternary carbon center by tandem (4 + 2)/(3 + 2) cycloaddition of a nitroalkene. The total synthesis of (-)-mesembrine

5. Application of (R)-(-)-2,2-diphenylcyclopentanol as the chiral auxiliary

6. Asymmetric nitroalkene [4+2] cycloadditions: enantioselective synthesis of 3-substituted and 3,4-disubstituted pyrrolidines

7. Nitroalkene (4 + 2) cycloaddition as a general and stereoselective route to the synthesis of 3,3- and 3,4-disubstituted pyrrolidines

8. A general method for the preparation of 2,2-disubstituted 1-nitroalkenes

9. Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

10. BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

11. Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder

12. Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors

14. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1

18. Identification and Preclinical Pharmacology of theγ-Secretase Modulator BMS-869780

19. Total synthesis of (-)(+)-batrachotoxinin A

22. Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor

23. Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor

24. P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid β Reduction by β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice

27. Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors

37. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.

38. Microwave-assisted synthesis and chiral HPLC separation of <SUP>18</SUP>F-labeled MaxiPost<SC>™</SC>. An agent for post-stroke neuroprotection

42. Preclinical Characterization of ( R )-3-((3 S ,4 S )-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N -Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder.

43. Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780.

44. Catalytic asymmetric diazoacetate cyclopropanation of 1-tosyl-3-vinylindoles. A route to conformationally restricted homotryptamines.

Catalog

Books, media, physical & digital resources